GlassScriptPhysician profile
Ashley D Pierson
NPI 1609213800
$5,274.37
in general payments reported to CMS, 2019-2025
20 companies · $1,289 in 2025
The $1,289 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $594 · 2023: $1,215 · 2024: $1,893 · 2025: $1,289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,265 · Education: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,264.97 |
| Education | $131.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,040.85 | 2023-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $843.98 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $543.37 | 2021-2025 | Ilumya, Blu-U, Odomzo |
| Abbvie INC. | $528.74 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $439.73 | 2022-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $437.32 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $318.16 | 2021-2025 | Bimzelx, Cimzia |
| Amgen INC. | $300.47 | 2021-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $279.35 | 2022-2025 | Tremfya, Stelara, Simponi Aria |
| Mayne Pharma Commercial LLC | $117.12 | 2023-2025 | |
| Incyte Corporation | $99.42 | 2022-2025 | Opzelura |
| Pfizer INC. | $86.90 | 2021-2023 | |
| Galderma Laboratories, L.P. | $79.23 | 2025 | Nemluvio |
| Biofrontera INC. | $32.86 | 2022 | |
| Leo Pharma INC. | $29.21 | 2022-2025 | Anzupgo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $23.50 | 2023 | Poteligeo |
| Genzyme Corporation | $22.97 | 2023 | |
| Dermavant Sciences, INC. | $18.25 | 2024 | Vtama |
| Organon LLC | $16.89 | 2025 | Vtama |
| Biowound Solutions, INC. | $16.05 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Pierson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.